Advanced Search

Study Preview



Study Title and Description

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.



Key Questions Addressed
3 Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.
Author McClung MR., Siris E., Cummings S., Bolognese M., Ettinger M., Moffett A., Emkey R., Day W., Somayaji V., Lee A.
Country Oregon Osteoporosis Center, Portland, OR 97213, USA. mmcclung@orost.com
Year -- Not Found --
Numbers Pubmed ID: 16735934

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.